Evaluation of dosing strategy for pembrolizumab for oncology indications

Por Freshwater, Tomoko, Kondic, Anna, Ahamadi, Malidi, Li, Claire H., de Greef, Rik, de Alwis, Dinesh, Stone, Julie A.
Publicado no J Immunother Cancer (2017)

Effect of Tipranavir-Ritonavir on Pharmacokinetics of Raltegravir

Por Hanley, William D., Wenning, Larissa A., Moreau, Allison, Kost, James T., Mangin, Eric, Shamp, Trisha, Stone, Julie A., Gottesdiener, Keith M., Wagner, John A., Iwamoto, Marian
Publicado em 2009

Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients

Por Li, Chi-Chung, Sun, Peng, Dong, Yingwen, Bi, Sheng, Desai, Rajesh, Dockendorf, Marissa Fallon, Kartsonis, Nicholas A., Ngai, Angela L., Bradshaw, Susan, Stone, Julie A.
Publicado em 2011

Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women

Por Anderson, Matt S, Hanley, William D, Moreau, Allison R, Jin, Bo, Bieberdorf, Frederick A, Kost, James T, Wenning, Larissa A, Stone, Julie A, Wagner, John A, Iwamoto, Marian
Publicado em 2011

Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Hea...

Por Anderson, Matt S., Kakuda, Thomas N., Hanley, William, Miller, Jutta, Kost, James T., Stoltz, Randall, Wenning, Larissa A., Stone, Julie A., Hoetelmans, Richard M. W., Wagner, John A., Iwamoto, Marian
Publicado em 2008

Single-Dose Pharmacokinetics of Indinavir and the Effect of Food

Por Yeh, Kuang C., Deutsch, Paul J., Haddix, Heidi, Hesney, Michael, Hoagland, Vicki, Ju, William D., Justice, Steven J., Osborne, Barbara, Sterrett, Andrew T., Stone, Julie A., Woolf, Eric, Waldman, Scott
Publicado em 1998

Single-Dose Pharmacokinetics of Indinavir and the Effect of Food

Por Yeh, Kuang C., Deutsch, Paul J., Haddix, Heidi, Hesney, Michael, Hoagland, Vicki, Ju, William D., Justice, Steven J., Osborne, Barbara, Sterrett, Andrew T., Stone, Julie A., Woolf, Eric, Waldman, Scott
Publicado em 1998

Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers

Por Neely, Michael, Jafri, Hasan S., Seibel, Nita, Knapp, Katherine, Adamson, Peter C., Bradshaw, Susan K., Strohmaier, Kim M., Sun, Peng, Bi, Sheng, Dockendorf, Marissa Fallon, Stone, Julie A., Kartsonis, Nicholas A.
Publicado em 2009

Model-Based Decision Making in Early Clinical Development: Minimizing the Impact of a Blood Pressure Adverse Event

Por Stroh, Mark, Addy, Carol, Wu, Yunhui, Aubrey Stoch, S., Pourkavoos, Nazaneen, Groff, Michelle, Xu, Yang, Wagner, John, Gottesdiener, Keith, Shadle, Craig, Wang, Hong, Manser, Kimberly, Winchell, Gregory A., Stone, Julie A.
Publicado em 2009

Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men

Por Stone, Julie A., Holland, Sherry D., Wickersham, Peter J., Sterrett, Andrew, Schwartz, Michael, Bonfiglio, Cynthia, Hesney, Michael, Winchell, Gregory A., Deutsch, Paul J., Greenberg, Howard, Hunt, Thomas L., Waldman, Scott A.
Publicado em 2002

Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

Por Wenning, Larissa A., Friedman, Evan J., Kost, James T., Breidinger, Sheila A., Stek, Jon E., Lasseter, Kenneth C., Gottesdiener, Keith M., Chen, Joshua, Teppler, Hedy, Wagner, John A., Stone, Julie A., Iwamoto, Marian
Publicado em 2008

Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics

Por Iwamoto, Marian, Hanley, William D., Petry, Amelia S., Friedman, Evan J., Kost, James T., Breidinger, Sheila A., Lasseter, Kenneth C., Robson, Richard, Lunde, Norman M., Wenning, Larissa A., Stone, Julie A., Wagner, John A.
Publicado em 2009

A Semi-mechanistic Model for the Effects of a Novel Glucagon Receptor Antagonist on Glucagon and the Interaction Between Glucose, Glucagon, and Insulin Applied to Adaptive Phase II...

Por Peng, Joanna Z., Denney, William S., Musser, Bret J., Liu, Rong, Tsai, Kuenhi, Fang, Lanyan, Reitman, Marc L., Troyer, Matthew D., Engel, Samuel S., Xu, Lei, Stoch, Aubrey, Stone, Julie A., Kowalski, Ken G.
Publicado no AAPS J (2014)

Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics – results from single oral dose studies in healthy...

Por Stoch, S Aubrey, Zajic, Stefan, Stone, Julie A, Miller, Deborah L, Bortel, Lucas, Lasseter, Kenneth C, Pramanik, Barnali, Cilissen, Caroline, Liu, Qi, Liu, Lida, Scott, Boyd B, Panebianco, Deborah, Ding, Yu, Gottesdiener, Keith, Wagner, John A
Publicado em 2013

Potential for Interactions between Caspofungin and Nelfinavir or Rifampin

Por Stone, Julie A., Migoya, Elizabeth M., Hickey, Lisa, Winchell, Gregory A., Deutsch, Paul J., Ghosh, Kalyan, Freeman, Amanda, Bi, Sheng, Desai, Rajesh, Dilzer, Stacy C., Lasseter, Kenneth C., Kraft, Walter K., Greenberg, Howard, Waldman, Scott A.
Publicado em 2004

Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir

Por Iwamoto, Marian, Wenning, Larissa A., Petry, Amelia S., Laethem, Martine, De Smet, Marina, Kost, James T., Breidinger, Sheila A., Mangin, Eric C., Azrolan, Neal, Greenberg, Howard E., Haazen, Wouter, Stone, Julie A., Gottesdiener, Keith M., Wagner, John A.
Publicado em 2008

Disposition of Caspofungin: Role of Distribution in Determining Pharmacokinetics in Plasma

Por Stone, Julie A., Xu, Xin, Winchell, Gregory A., Deutsch, Paul J., Pearson, Paul G., Migoya, Elizabeth M., Mistry, Goutam C., Xi, Liwen, Miller, Alisha, Sandhu, Punam, Singh, Romi, deLuna, Florencia, Dilzer, Stacy C., Lasseter, Kenneth C.
Publicado em 2004

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

Por Wenning, Larissa A., Hanley, William D., Brainard, Diana M., Petry, Amelia S., Ghosh, Kalyan, Jin, Bo, Mangin, Eric, Marbury, Thomas C., Berg, Jolene K., Chodakewitz, Jeffrey A., Stone, Julie A., Gottesdiener, Keith M., Wagner, John A., Iwamoto, Marian
Publicado em 2009

Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age

Por Sáez-Llorens, Xavier, Macias, Mercedes, Maiya, Padmanabha, Pineros, Juan, Jafri, Hasan S., Chatterjee, Archana, Ruiz, Gloria, Raghavan, Janaki, Bradshaw, Susan K., Kartsonis, Nicholas A., Sun, Peng, Strohmaier, Kim M., Fallon, Marissa, Bi, Sheng, Stone, Julie A., Chow, Joseph W.
Publicado em 2009

Pharmacokinetic–pharmacodynamic studies of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor MK-0916 in healthy subjects

Por Wright, D Hamish, Stone, Julie A, Crumley, Tami M, Wenning, Larissa, Zheng, Wei, Yan, Kerri, Yang, Amy Yifan, Sun, Li, Cilissen, Caroline, Ramael, Steven, Hermanowski-Vosatka, Anne, Langdon, Ronald B, Gottesdiener, Keith M, Wagner, John A, Lai, Eseng
Publicado em 2013